Loading
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Latest filing published 24 Sept 2026 for Theravance Biopharma, Inc..
Insider track record
Disclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
No signal scores available.
Alsup Laurie Smaldone: trading record in brief
Alsup Laurie Smaldone (board member) discloses dealings in 2 companies, chiefly Theravance Biopharma, Inc. and Arvinas, Inc. Over a trading history stretching from 13 February 2018 to 23 September 2026, the count stands at 15 filings.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.
The latest filing, published on 24 September 2026, reports a transaction in Theravance Biopharma, Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. For comparison, the SEC allows two business days to file a Form 4. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Alsup Laurie Smaldone
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations10 total
74,980 sharesOrdinary SharesSEC:0001589602-26-000005:0
6,009 sharesOrdinary SharesSEC:0001589602-26-000005:1
15,527 sharesCommon StockSEC:0001628280-26-045788:0
16,025 shares0Common StockSEC:0001655759-25-000124:0
10,649 shares0Ordinary SharesSEC:0001415889-25-013997:0
5,899 shares0Common StockSEC:0001655759-24-000080:0
10,537 shares0Ordinary SharesSEC:0001415889-24-012906:0
4,121 shares0Common StockSEC:0001655759-23-000067:0
9,132 shares0Ordinary SharesSEC:0001415889-23-007372:0
9,852 shares0Ordinary SharesSEC:0001415889-22-004326:0
10 of 10 declarations
